RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/16185329http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/16185329http://www.w3.org/2000/01/rdf-schema#comment"Human leukocyte antigen (HLA) variations may affect immune response to human papillomavirus infection and subsequent cervical neoplasia risk. We investigated the frequency and relationship between HLA-A-B and HLA-A-B-DR haplotypes among women with cervical cancer/high-grade lesions (n=365) and cytologically normal population controls (n=681) within three cervical neoplasia studies in the US and Costa Rica. Notable differences in haplotype frequencies were observed; the HLA-A*01-B*08 haplotype occurred in >5% of US Caucasians but in <1% of Costa Ricans. The most prevalent HLA-A*24-B*40-DR*04 haplotype in Costa Rica (5%) was found in <1% of US Caucasians. No HLA haplotype was significantly associated with cervical neoplasia, suggesting that individual allele associations reported to date (e.g. HLA-DR*13) are not likely explained by underlying haplotypes."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.org/dc/terms/identifier"doi:10.1111/j.1399-0039.2005.00478.x"xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Carrington M."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Gao X."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Martin M.P."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Wang S.S."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Herrero R."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Hildesheim A."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Schiffman M."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Bratti M.C."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Sherman M.E."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Zaino R.J."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/author"Carreon J.D."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/date"2005"xsd:gYear
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/name"Tissue Antigens"xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/pages"321-324"xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/title"Human leukocyte antigen class I and II haplotypes and risk of cervical cancer."xsd:string
http://purl.uniprot.org/citations/16185329http://purl.uniprot.org/core/volume"66"xsd:string
http://purl.uniprot.org/citations/16185329http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/16185329
http://purl.uniprot.org/citations/16185329http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/16185329
http://purl.uniprot.org/uniprot/#_A0A0A7C3H3-mappedCitation-16185329http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16185329
http://purl.uniprot.org/uniprot/#_A0A0A7C3I1-mappedCitation-16185329http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16185329
http://purl.uniprot.org/uniprot/#_A0A0A7C3I5-mappedCitation-16185329http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16185329
http://purl.uniprot.org/uniprot/#_A0A0A7C548-mappedCitation-16185329http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/16185329